Amarin Corp Plc (AMRN)

[Insync_2000]

Talking about the addressable market. Did a bit of back of the envelope analysis and the potential of this company is massive. Right now Amarin is selling approximately 7.6 million capsules a week which when divided by 4 capsules a day and 7 days a week suggests that the current count on Vascepa is approximately 270,000 patience. Recognizing that at $1,650 per patient, per year, Amarin will generate $450 million, which can roughly be translated to a half billion dollars in revenue for every 300,000 patience.

When one digests the multiple of millions in the US alone that are candidates for this drug, the potential inherent in this company is absolutely mind boggling. There has been talk that 10s of million are candidates in the US alone and at a half billion dollars for every 300 million patience, revenue could easily get into the 15 to 20 billion dollar range.

Putting even a 3 X multiplier to gross revenue is …. holy shit ... I will leave the rest to your imagination.